HTG Molecular

In Brief This Week: Becton Dickinson, Quidel, Lucid Diagnostics, AnchorDx, and 54gene

In Brief This Week: Hologic, NeoGenomics, Natera, Saga Diagnostics, and More

HTG Molecular Preliminary Q1 Revenues Fall 56 Percent

HTG Molecular Diagnostics FY 2020 Revenues Fall 56 Percent

HTG Molecular Preliminary 2020 Revenues Drop 56 Percent

HTG Molecular Completes 1-For-15 Reverse Stock Split

HTG to Expand Disease Reach With New Whole-Transcriptome Profiling Product Mid-2021

HTG Molecular Diagnostics Q3 Revenues Drop 67 Percent

BioSpyder Seeks Noninfringement Judgment in HTG Molecular Patent Dispute

HTG Molecular Q2 Revenues Drop 66 Percent as COVID-19 Forces Global Facility Closures

HTG Molecular Diagnostics, Qiagen Ink CDx Commercialization, Distribution Agreement

HTG Molecular Inks $10M Secured Credit Agreement

HTG Molecular Signs Three European Distribution Agreements

HTG Molecular Diagnostics Q1 Revenues Drop 31 Percent Due to COVID-19 Global Facility Closures

HTG Molecular Diagnostics' FY 2019 Revenues Drop 11 Percent

HTG Molecular Expects 11 Percent Drop in 2019 Revenues

HTG Molecular Diagnostics Files for $20M Stock Offering

HTG Molecular Diagnostics Revenues Grow 15 Percent; Firm Lowers Full-Year Guidance

In Brief This Week: Ortho Clinical Diagnostics, Thermo Fisher Scientific, Novigenix, HTG Molecular Diagnostics